Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bone marrow in megakaryocytic disorders.

R Burkhardt1

  • 1Abteilung für Knochenmarksdiagnostik an der Medizinischen Klinik Innenstadt, Universität München.

Hematology/Oncology Clinics of North America
|December 1, 1988
PubMed
Summary

Megakaryocytic disorders cause serious health issues like bleeding and clotting. Bone marrow analysis reveals significant megakaryocyte abnormalities, but their impact remains largely unknown.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

BioXmark for high-precision radiotherapy in an orthotopic pancreatic tumor mouse model : Experiences with a liquid fiducial marker.

Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]·2017
Same author

[Chronic Obstructive Pulmonary Disease (COPD) - Rational Diagnostics and Therapy].

Pneumologie (Stuttgart, Germany)·2016
Same author

[PCSK9 - "missing link" in familial hypercholesterolemia : New therapeutic options in hypercholesterolemia and coronary artery disease].

Herz·2016
Same author

Monitoring of WT1 expression in PB and CD34(+) donor chimerism of BM predicts early relapse in AML and MDS patients after hematopoietic cell transplantation with reduced-intensity conditioning.

Leukemia·2010
Same author

Role of flap tension in primary wound closure of mucoperiosteal flaps: a prospective cohort study.

Clinical oral implants research·2010
Same author

Soft tissue dehiscence coverage around endosseous implants: a prospective cohort study.

Clinical oral implants research·2008

Area of Science:

  • Hematology
  • Oncology
  • Pathology

Background:

  • Megakaryocytic disorders lead to myelofibrosis, osteomyelosclerosis, hemorrhage, and thrombosis.
  • These disorders present in four main structural types: myeloproliferation, dysmegakaryocytosis, amegakaryocytosis, and secondary megakaryocytosis.
  • While myeloproliferation and amegakaryocytosis are histologically defined, dysmegakaryocytosis and secondary megakaryocytosis require clinical correlation.

Purpose of the Study:

  • To highlight the significant quantitative and qualitative anomalies of megakaryocytes observed in bone marrow biopsies across different megakaryocytic disorder types.
  • To emphasize the lack of understanding regarding the pathophysiologic impact of these observed megakaryocyte changes.
  • To advocate for further research into the functional consequences of these morphological abnormalities.

Main Methods:

  • Bone marrow biopsy analysis.
  • Histopathological examination of megakaryocytes.
  • Clinical data correlation with morphological findings.

Main Results:

  • Marked quantitative and qualitative anomalies in megakaryocytes were identified across all studied groups.
  • Observed anomalies include isolation, pleomorphism, nuclear degeneration, cytoplasmic immaturity, vacuolization, and disruption.
  • These changes were present even in disorders primarily defined by clinical findings.

Conclusions:

  • Megakaryocytic disorders exhibit substantial megakaryocyte abnormalities detectable via bone marrow biopsy.
  • The pathophysiologic significance of these morphological changes is currently poorly understood.
  • Further investigation is warranted to elucidate the clinical impact of these megakaryocyte alterations.

Related Experiment Videos